Keyphrases
Integrated Activities
62%
Physiologically-based Pharmacokinetic Model
53%
Peptide Receptor Radionuclide Therapy
44%
Activity Coefficient
35%
Kidney
31%
Treatment Planning
27%
Biokinetics
24%
Model Selection
21%
Nonlinear Mixed Effects
19%
Absorbed Dose
18%
Single Time Point
18%
Liver
17%
Molecular Radiotherapy
16%
Mathematical Phantoms
16%
Fitting Function
14%
Tumor
14%
Physiological Parameters
13%
Relative Standard Deviation
12%
Point Dosimetry
12%
Spleen
12%
Akaike Weights
12%
Pharmacokinetic Model
12%
Sampling Schedule
12%
Phantom
12%
Global Sensitivity Analysis
12%
Lutetium-177 (177Lu)
11%
Bi-exponential
9%
Receptor Density
9%
Organs at Risk
8%
NONMEM
8%
Population-based Model
8%
Exponential Function
8%
Simulation Study
8%
Quantitative Imaging
8%
Pharmacokinetic Parameters
8%
Coefficient of Variation
8%
Pharmacokinetics
7%
Root Mean Square Error
7%
Shared Parameters
7%
Lutetium
7%
Radionuclide Therapy
7%
Activity Data
6%
Population-based Methods
6%
Gallium-68
6%
Goodness-of-fit
6%
Single-photon Emission Computed Tomography (SPECT)
6%
Dynamic PET
6%
Point Spread Function Estimation
6%
Preclinical SPECT
6%
Prism Treatment
6%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetics
100%
Receptor
73%
Radioisotope
69%
Model Selection
48%
Neoplasm
48%
Dosimetry
43%
Lutetium 177
35%
Biodistribution
21%
Indium 111
20%
Radiopharmaceutical Agent
18%
Akaike Information Criterion
15%
Mouse
12%
Kidney Tumour
11%
Pharmacokinetic Parameter
9%
Yttrium 90
8%
Neuroendocrine Tumor
8%
Gallium 68
7%
Prostate Specific Membrane Antigen
7%
Physiologically Based Pharmacokinetic Modelling
7%
Sodium 22
6%
Chimeric Antigen Receptor
6%
Lutetium
6%
Fluorine 18
6%
Pet Animal
6%
Monoclonal Antibody
6%
Immunoglobulin G Antibody
6%
Quantitative Pharmacology
6%
Hydroxyapatite
6%
Immunoglobulin G1 Antibody
6%
Liver Cancer
6%
Lysine
6%
Arginine
6%
